Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERSEUS: SAR442168 vs placebo in primary progressive multiple sclerosis
CTR20202631Phase 3Completed
- Sponsor
- Sanofi
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tolebrutinib in primary progressive multiple sclerosis (PPMS), sponsored by Sanofi. Started Dec 2020; status: completed.
02
Drugs
tolebrutinib
03
Conditions
primary progressive multiple sclerosis (PPMS)
Beyond the preview
Go deeper on CTR20202631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20202631.